Healthcare speed-scaling platform offers clinical validation, regulatory support, mentorship, and investor access to startups working across preventive health, oncology, genomics, diagnostics, and digital health
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
The decision was driven by results from the Phase III CAPItello-281 trial,
Approval is based on results from the phase 3 OASIS 4 clinical trial
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors
The newly constituted committee will facilitate timely brain stem death certification, supporting transparent organ donation processes and expanding opportunities for patients awaiting transplants
Subscribe To Our Newsletter & Stay Updated
